# Marina Noris

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/marina-noris/

## Facts

| Field | Value |
| --- | --- |
| Citations | 24,741 |
| Field | Complement system in diseases |
| h-index | 79 |
| i10-index | 202 |
| Last Known Institution | Mario Negri Institute for Pharmacological Research |
| OpenAlex ID | https://openalex.org/A5106670144 |
| ORCID iD | https://orcid.org/0000-0001-7651-5033 |
| Works | 351 |

## Researcher papers

- [Relative Role of Genetic Complement Abnormalities in Sporadic and Familial aHUS and Their Impact on Clinical Phenotype](https://scholariq.org/papers/relative-role-of-genetic-complement-abnormalities-in-sporadic-and-familial-ahus/)
- [Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome](https://scholariq.org/papers/genetics-of-hus-the-impact-of-mcp-cfh-and-if-mutations-on-clinical-presentation/)
- [Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference](https://scholariq.org/papers/atypical-hemolytic-uremic-syndrome-and-c3-glomerulopathy-conclusions-from-a/)
- [C3 glomerulopathy — understanding a rare complement-driven renal disease](https://scholariq.org/papers/c3-glomerulopathy-understanding-a-rare-complement-driven-renal-disease/)
- [Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome](https://scholariq.org/papers/mutations-in-factor-h-reduce-binding-affinity-to-c3b-and-heparin-and-surface/)
- [Dynamics of complement activation in aHUS and how to monitor eculizumab therapy](https://scholariq.org/papers/dynamics-of-complement-activation-in-ahus-and-how-to-monitor-eculizumab-therapy/)
- [Atypical aHUS: State of the art](https://scholariq.org/papers/atypical-ahus-state-of-the-art/)
- [Factor H family proteins: on complement, microbes and human diseases](https://scholariq.org/papers/factor-h-family-proteins-on-complement-microbes-and-human-diseases/)
- [The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference](https://scholariq.org/papers/the-role-of-complement-in-kidney-disease-conclusions-from-a-kidney-disease/)

## Researcher topics

- [Complement system in diseases](https://scholariq.org/topics/complement-system-in-diseases/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Blood groups and transfusion](https://scholariq.org/topics/blood-groups-and-transfusion/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)
- [Platelet Disorders and Treatments](https://scholariq.org/topics/platelet-disorders-and-treatments/)

## Researcher university

- [Mario Negri Institute for Pharmacological Research](https://scholariq.org/institutions/mario-negri-institute-for-pharmacological-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.